Ticker brief

GMAB

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
9
authors 14d
8

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-06-29 → 2026-06-30 · now +0.34 (−1 bearish … +1 bullish)
Who spoke8
authorgradetrader scoresignalsmean sent
@FutsallerNB+0.422+0.50
@PersimmonTIA-0.321+0.20
@faststocknewssC-2.021+0.35
@OzmosiHealthC·1+0.50
@NewsquawkB·1+0.50
@FiercePharmaB+1.391+0.35
@BiopharmIQB·1+0.10
@OracleNYSEC+0.491+0.10
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-06-30@FutsallerN+0.50US market wrap with macro prints and multiple direct company events; first six tickers retained.·
2026-06-30@FutsallerN+0.50Japanese market wrap with macro data and company-specific earnings, trial and probe news.·
2026-06-30@OracleNYSE+0.10FT says Anthropic launches Claude Science in push for pharma revenue.·
2026-06-30@BiopharmIQ+0.10Biotech open news list with positive percentage moves and catalysts.·
2026-06-30@FiercePharma+0.35Positive phase 3 combination trial renews confidence for Epkinly.·
2026-06-30@Newsquawk+0.50US pre-market movers cite regulatory, earnings, M&A and trial-result catalysts.·
2026-06-29@OzmosiHealth+0.50Genmab announces positive Phase 3 results with statistically significant PFS improvement.·
2026-06-29@faststocknewss+0.35AbbVie reported positive Phase 3 epcoritamab data in lymphoma, developed with Genmab.·
2026-06-29@PersimmonTI+0.20Says list of non-traditional XBI acquirers continues to grow, a good sign.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.